Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Eric Mark Green. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Eric Mark Green har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ECL / Ecolab Inc. | Director | 3 139 |
US:WST / West Pharmaceutical Services, Inc. | President, CEO and Board Chair, Director | 169 669 |
US:SIAL / Sigma-Aldrich Corporation | EVP & President, Research | 6 440 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Eric Mark Green. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Eric Mark Green som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 136 | 3 139 | 4,51 | 267,48 | 36 249 | 839 644 | |
2025-07-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 126 | 3 004 | 4,39 | ||||
2025-04-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 144 | 2 870 | 5,29 | 251,56 | 36 250 | 722 066 | |
2025-04-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 134 | 2 726 | 5,18 | ||||
2025-02-20 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
F - Taxes | −700 | 169 669 | −0,41 | 211,00 | −147 762 | 35 800 121 | |
2025-02-20 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | 2 461 | 170 369 | 1,47 | 211,00 | 519 269 | 35 947 883 | |
2025-01-03 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 154 | 2 586 | 6,35 | 234,64 | 36 250 | 606 740 | |
2025-01-03 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 144 | 2 427 | 6,30 | ||||
2024-10-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 143 | 2 283 | 6,66 | 254,34 | 36 251 | 580 667 | |
2024-10-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 133 | 2 137 | 6,62 | ||||
2024-08-08 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 9 000 | 161 908 | 5,89 | 59,64 | 536 760 | 9 656 201 |
2024-08-08 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −41 000 | 152 908 | −21,14 | 366,65 | −15 032 736 | 56 064 085 |
2024-08-08 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −15 684 | 193 908 | −7,48 | 366,66 | −5 750 678 | 71 098 140 |
2024-08-08 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −9 316 | 209 952 | −4,25 | 366,64 | −3 415 636 | 76 977 246 |
2024-08-08 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 41 000 | 218 908 | 23,05 | 59,64 | 2 445 240 | 13 055 681 |
2024-08-08 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 15 684 | 177 908 | 9,67 | 57,38 | 899 948 | 10 208 368 |
2024-08-08 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 9 316 | 162 224 | 6,09 | 57,38 | 534 552 | 9 308 420 |
2024-08-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 6 000 | 167 898 | 3,71 | 59,64 | 357 840 | 10 013 444 |
2024-08-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −30 732 | 161 898 | −15,95 | 304,71 | −9 364 409 | 49 332 301 |
2024-08-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 30 732 | 192 640 | 18,98 | 59,64 | 1 832 856 | 11 489 057 |
2024-07-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 144 | 2 004 | 7,77 | 238,84 | 34 491 | 478 590 | |
2024-07-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 141 | 1 856 | 8,24 | ||||
2024-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 9 000 | 161 908 | 5,89 | 59,64 | 536 760 | 9 656 201 |
2024-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −41 000 | 152 908 | −21,14 | 366,65 | −15 032 736 | 56 064 085 |
2024-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −15 684 | 193 908 | −7,48 | 366,66 | −5 750 678 | 71 098 140 |
2024-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −9 316 | 209 952 | −4,25 | 366,64 | −3 415 636 | 76 977 246 |
2024-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 41 000 | 218 908 | 23,05 | 59,64 | 2 445 240 | 13 055 681 |
2024-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 15 684 | 177 908 | 9,67 | 57,38 | 899 948 | 10 208 368 |
2024-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 9 316 | 162 224 | 6,09 | 57,38 | 534 552 | 9 308 420 |
2024-04-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 135 | 1 714 | 8,57 | 230,81 | 31 249 | 395 693 | |
2024-04-02 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 146 | 1 576 | 10,23 | ||||
2024-02-29 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 9 000 | 152 908 | 6,25 | 57,38 | 516 420 | 8 773 868 |
2024-02-29 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −64 132 | 152 908 | −29,55 | 359,85 | −23 077 971 | 55 024 157 |
2024-02-29 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 64 132 | 217 040 | 41,94 | 57,38 | 3 679 894 | 12 453 762 |
2024-02-22 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 6 567 | 148 203 | 4,64 | ||||
2024-01-03 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 151 | 1 430 | 11,81 | 198,63 | 29 999 | 283 956 | |
2024-01-03 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 157 | 1 276 | 14,06 | ||||
2023-12-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
G - Gift | −9 800 | 130 774 | −6,97 | 343,00 | −3 361 400 | 44 855 512 | |
2023-10-03 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 176 | 1 119 | 18,72 | 170,03 | 30 000 | 190 228 | |
2023-10-03 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 184 | 941 | 24,27 | ||||
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −100 | 140 574 | −0,07 | 398,87 | −39 887 | 56 070 786 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −1 100 | 140 674 | −0,78 | 397,90 | −437 686 | 55 973 713 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −7 532 | 141 774 | −5,04 | 397,18 | −2 991 531 | 56 309 293 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −6 700 | 149 306 | −4,29 | 396,13 | −2 654 040 | 59 143 918 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −7 684 | 156 006 | −4,69 | 395,07 | −3 035 743 | 61 633 839 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −8 329 | 163 690 | −4,84 | 394,17 | −3 283 075 | 64 522 376 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −7 055 | 172 019 | −3,94 | 393,13 | −2 773 539 | 67 626 035 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −4 500 | 179 074 | −2,45 | 392,16 | −1 764 699 | 70 224 852 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −1 000 | 183 574 | −0,54 | 389,62 | −389 620 | 71 524 136 |
2023-08-10 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 50 000 | 184 574 | 37,15 | 57,38 | 2 869 000 | 10 590 861 |
2023-07-05 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 161 | 757 | 27,08 | 185,88 | 30 000 | 140 771 | |
2023-07-05 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 168 | 596 | 39,31 | ||||
2023-05-11 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −500 | 134 574 | −0,37 | 365,46 | −182 729 | 49 181 177 |
2023-05-11 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −4 133 | 135 074 | −2,97 | 364,76 | −1 507 572 | 49 270 232 |
2023-05-11 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −12 648 | 139 207 | −8,33 | 363,94 | −4 603 055 | 50 662 387 |
2023-05-11 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −12 562 | 151 855 | −7,64 | 362,93 | −4 559 085 | 55 112 265 |
2023-05-11 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −14 157 | 164 417 | −7,93 | 361,95 | −5 124 081 | 59 510 238 |
2023-05-11 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 50 000 | 178 574 | 38,89 | 57,38 | 2 869 000 | 10 246 581 |
2023-04-04 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 182 | 428 | 74,11 | 164,81 | 30 000 | 70 479 | |
2023-04-04 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 190 | 246 | 338,59 | ||||
2023-03-28 |
|
5 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
G - Gift | −2 700 | 125 874 | −2,10 | 371,47 | −1 002 969 | 46 758 447 | |
2023-03-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −1 131 | 128 574 | −0,87 | 324,29 | −366 772 | 41 695 291 |
2023-03-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −5 277 | 123 297 | −4,10 | 323,38 | −1 706 478 | 39 871 861 |
2023-03-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −26 753 | 96 544 | −21,70 | 322,49 | −8 627 505 | 31 134 251 |
2023-03-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −7 685 | 88 859 | −7,96 | 321,61 | −2 471 602 | 28 578 308 |
2023-03-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −3 154 | 85 705 | −3,55 | 320,60 | −1 011 173 | 27 477 068 |
2023-03-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 50 000 | 135 705 | 58,34 | 57,38 | 2 869 000 | 7 786 758 |
2023-02-23 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 14 783 | 129 705 | 12,86 | 306,68 | 4 533 650 | 39 777 956 | |
2023-01-03 |
|
4 | ECL |
ECOLAB INC.
Common Stock |
A - Award | 56 | 56 | |||||
2022-12-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −1 100 | 114 922 | −0,95 | 241,46 | −265 611 | 27 749 604 |
2022-12-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −9 682 | 116 022 | −7,70 | 240,73 | −2 330 775 | 27 930 322 |
2022-12-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −10 752 | 125 704 | −7,88 | 239,70 | −2 577 224 | 30 130 918 |
2022-12-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −6 312 | 136 456 | −4,42 | 238,83 | −1 507 475 | 32 589 370 |
2022-12-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −9 408 | 142 768 | −6,18 | 237,67 | −2 235 977 | 33 931 348 |
2022-12-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
S - Sale | X | −6 746 | 152 176 | −4,24 | 236,95 | −1 598 457 | 36 057 941 |
2022-12-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
M - Exercise | X | 50 000 | 158 922 | 45,90 | 57,38 | 2 869 000 | 9 118 949 |
2022-02-24 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 22 104 | 108 922 | 25,46 | 369,13 | 8 159 250 | 40 206 410 | |
2022-02-24 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to buy) |
A - Award | 31 088 | 31 088 | |||||
2022-02-14 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
F - Taxes | −85 | 86 818 | −0,10 | 391,20 | −33 252 | 33 963 235 | |
2022-02-11 |
|
5 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
G - Gift | −3 150 | 86 903 | −3,50 | 325,00 | −1 023 750 | 28 243 503 | |
2021-02-25 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to buy) |
A - Award | 43 652 | 43 652 | |||||
2021-02-24 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 17 767 | 90 053 | 24,58 | 272,65 | 4 844 173 | 24 552 974 | |
2021-02-17 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
F - Taxes | −92 | 72 286 | −0,13 | 294,01 | −27 049 | 21 252 832 | |
2020-06-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
F - Taxes | −5 | 72 378 | −0,01 | 197,94 | −990 | 14 326 518 | |
2020-04-28 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
F - Taxes | −5 858 | 72 373 | −7,49 | 195,54 | −1 145 473 | 14 151 833 | |
2020-02-25 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
F - Taxes | −192 | 78 231 | −0,24 | 170,16 | −32 671 | 13 311 802 | |
2020-02-20 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to Buy) |
A - Award | 57 384 | 57 384 | |||||
2020-02-20 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 9 392 | 78 423 | 13,61 | 173,22 | 1 626 882 | 13 584 447 | |
2019-02-21 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to buy) |
A - Award | 85 680 | 85 680 | 102,51 | 8 783 057 | 8 783 057 | ||
2019-02-21 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 6 034 | 69 031 | 9,58 | 102,51 | 618 545 | 7 076 377 | |
2018-04-26 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
F - Taxes | −7 716 | 62 997 | −10,91 | 92,00 | −709 872 | 5 795 732 | |
2018-02-22 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to buy) |
A - Award | 87 720 | 87 720 | 89,64 | 7 863 221 | 7 863 221 | ||
2018-02-15 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 9 836 | 70 713 | 16,16 | 93,00 | 914 748 | 6 576 317 | |
2018-02-15 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 1 421 | 60 877 | 2,39 | 93,00 | 132 153 | 5 661 569 | |
2017-02-22 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to buy) |
A - Award | 83 616 | 83 616 | 83,47 | 6 979 428 | 6 979 428 | ||
2017-02-16 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 6 225 | 59 456 | 11,69 | 86,93 | 541 139 | 5 168 518 | |
2017-02-16 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 1 540 | 53 231 | 2,98 | 86,93 | 133 872 | 4 627 378 | |
2017-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 14 | 249 | 5,99 | 84,83 | 1 192 | 21 091 | |
2016-12-19 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 14 | 235 | 6,39 | 84,63 | 1 192 | 19 852 | |
2016-12-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 15 | 220 | 7,19 | 80,57 | 1 192 | 17 765 | |
2016-11-21 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 15 | 206 | 7,80 | 80,14 | 1 192 | 16 484 | |
2016-11-07 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 16 | 191 | 9,04 | 75,39 | 1 192 | 14 385 | |
2016-10-24 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 17 | 175 | 10,50 | 71,68 | 1 192 | 12 544 | |
2016-10-11 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 16 | 158 | 11,10 | 75,44 | 1 192 | 11 937 | |
2016-09-26 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 16 | 142 | 13,04 | 72,55 | 1 192 | 10 333 | |
2016-09-12 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 15 | 126 | 13,38 | 80,19 | 1 192 | 10 103 | |
2016-08-29 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 15 | 111 | 15,15 | 81,56 | 1 192 | 9 063 | |
2016-08-15 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 15 | 97 | 18,00 | 81,00 | 1 192 | 7 817 | |
2016-08-01 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 15 | 82 | 22,19 | 80,28 | 1 192 | 6 566 | |
2016-07-18 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 15 | 67 | 29,70 | 77,79 | 1 192 | 5 207 | |
2016-07-06 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 16 | 52 | 43,77 | 75,89 | 1 192 | 3 917 | |
2016-06-20 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 19 | 36 | 115,76 | 73,89 | 1 423 | 2 652 | |
2016-06-06 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 14 | 17 | 615,17 | 75,25 | 1 077 | 1 252 | |
2016-05-23 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 | 2 | 72,73 | 169 | 169 | ||
2016-04-26 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
A - Award | 164 320 | 164 320 | 57,38 | 9 428 682 | 9 428 682 | ||
2016-04-26 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
A - Award | 53 996 | 53 996 | 57,38 | 3 098 290 | 3 098 290 | ||
2016-04-26 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
A - Award | 79 816 | 79 816 | 57,38 | 4 579 842 | 4 579 842 | ||
2016-04-26 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 30 499 | 30 499 | |||||
2016-03-15 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
A - Award | 86 732 | 86 732 | 59,64 | 5 172 696 | 5 172 696 | ||
2016-03-15 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 205 | 51 119 | 4,51 | 59,64 | 131 506 | 3 048 724 | |
2016-02-25 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
A - Award | 73 724 | 73 724 | 59,64 | 4 396 899 | 4 396 899 | ||
2016-02-25 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 205 | 51 119 | 4,51 | 59,64 | 131 506 | 3 048 724 | |
2015-07-06 |
|
4/A | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 30 499 | 30 499 | |||||
2015-05-22 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
P - Purchase | 18 300 | 18 300 | 54,89 | 1 004 441 | 1 004 441 | ||
2015-04-28 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy) |
A - Award | 164 320 | 164 320 | 57,38 | 9 428 682 | 9 428 682 | ||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right to Buy |
M - Exercise | −3 756 | 6 440 | −36,84 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right to Buy |
M - Exercise | −10 810 | 4 096 | −72,52 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right to Buy |
M - Exercise | −6 678 | 0 | −100,00 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −1 422 | 0 | −100,00 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy |
M - Exercise | −7 950 | 0 | −100,00 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option, Right to Buy |
M - Exercise | −1 600 | 0 | −100,00 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy |
M - Exercise | −5 674 | 0 | −100,00 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −2 826 | 0 | −100,00 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right to Buy |
M - Exercise | −3 268 | 0 | −100,00 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −1 732 | 0 | −100,00 | ||||
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −30 760 | 24 964 | −55,20 | 138,20 | −4 251 032 | 3 450 025 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 3 756 | 55 724 | 7,23 | 93,07 | 349 571 | 5 186 233 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 10 810 | 51 968 | 26,26 | 76,34 | 825 235 | 3 967 237 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 6 678 | 41 158 | 19,37 | 70,32 | 469 597 | 2 894 231 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 1 422 | 34 480 | 4,30 | 70,32 | 99 995 | 2 424 634 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 7 950 | 33 058 | 31,66 | 62,49 | 496 796 | 2 065 794 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 1 600 | 25 108 | 6,81 | 62,49 | 99 984 | 1 568 999 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 5 674 | 23 508 | 31,82 | 48,61 | 275 813 | 1 142 724 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 2 826 | 17 834 | 18,83 | 48,61 | 137 372 | 866 911 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 3 268 | 15 008 | 27,84 | 37,56 | 122 746 | 563 700 | |
2015-03-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 1 732 | 11 740 | 17,31 | 37,56 | 65 054 | 440 954 | |
2015-03-11 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
F - Taxes | −621 | 10 008 | −5,84 | 138,07 | −85 741 | 1 381 805 | |
2015-03-11 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
A - Award | 1 861 | 10 629 | 21,22 | ||||
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right to Buy |
M - Exercise | −6 550 | 0 | −100,00 | ||||
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −1 850 | 0 | −100,00 | ||||
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right to Buy |
M - Exercise | −4 750 | 0 | −100,00 | ||||
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −2 750 | 0 | −100,00 | ||||
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | −6 550 | 8 768 | −42,76 | 136,35 | −893 070 | 1 195 486 | |
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 6 550 | 15 318 | 74,70 | 52,76 | 345 578 | 808 178 | |
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | −1 850 | 8 768 | −17,42 | 136,35 | −252 241 | 1 195 486 | |
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 1 850 | 10 618 | 21,10 | 52,76 | 97 606 | 560 206 | |
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | −4 750 | 8 768 | −35,14 | 136,35 | −647 646 | 1 195 486 | |
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 4 750 | 13 518 | 54,17 | 41,62 | 197 695 | 562 619 | |
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | −2 750 | 8 768 | −23,88 | 136,35 | −374 953 | 1 195 486 | |
2014-12-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 2 750 | 11 518 | 31,36 | 41,62 | 114 455 | 479 379 | |
2014-08-12 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Restricted Stock Unit |
M - Exercise | −2 000 | 0 | −100,00 | ||||
2014-08-12 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
F - Taxes | −668 | 8 768 | −7,08 | 101,93 | −68 089 | 893 722 | |
2014-08-12 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 2 000 | 9 436 | 26,90 | ||||
2014-05-30 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2014-05-30 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −3 400 | 0 | −100,00 | ||||
2014-05-30 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −4 544 | 7 436 | −37,93 | 98,03 | −445 444 | 728 944 | |
2014-05-30 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 2 500 | 11 980 | 26,37 | 34,03 | 85 075 | 407 679 | |
2014-05-30 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 3 400 | 9 480 | 55,92 | 28,82 | 98 005 | 273 261 | |
2014-02-12 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Restricted Stock Unit |
A - Award | 1 735 | 1 735 | |||||
2014-02-12 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right to Buy |
A - Award | 10 196 | 10 196 | |||||
2014-02-12 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
A - Award | 1 074 | 1 074 | |||||
2014-02-12 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
F - Taxes | −619 | 6 080 | −9,24 | 93,07 | −57 610 | 565 866 | |
2014-02-12 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
A - Award | 1 755 | 6 699 | 35,50 | ||||
2013-05-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −3 400 | 1 600 | −68,00 | ||||
2013-05-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −2 000 | 0 | −100,00 | ||||
2013-05-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −900 | 4 944 | −15,40 | 83,02 | −74 718 | 410 451 | |
2013-05-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −1 000 | 5 844 | −14,61 | 83,02 | −83 020 | 485 169 | |
2013-05-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 3 400 | 6 844 | 98,72 | 28,82 | 98 005 | 197 278 | |
2013-05-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 2 000 | 3 444 | 138,50 | 28,66 | 57 320 | 98 705 | |
2013-05-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −2 000 | 1 444 | −58,07 | 83,08 | −166 160 | 119 968 | |
2013-02-13 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Restricted Stock Unit |
A - Award | 2 000 | 2 000 | |||||
2013-02-13 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right to Buy |
A - Award | 14 906 | 14 906 | |||||
2013-02-13 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
A - Award | 1 309 | 1 309 | |||||
2013-02-13 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
A - Award | 1 044 | 3 444 | 43,50 | ||||
2013-01-08 | 3 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
2 400 | ||||||||
2013-01-08 | 3 | SIAL |
SIGMA ALDRICH CORP
Common Stock Units |
3 567 | ||||||||
2011-02-22 |
|
4/A | SIAL |
SIGMA ALDRICH CORP
Common Stock, $1 Par Value |
A - Award | 600 | 4 140 | 16,95 | 62,49 | 37 494 | 258 709 | |
2011-02-22 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock, $1 Par Value |
A - Award | 1 200 | 4 740 | 33,90 | 62,49 | 74 988 | 296 203 | |
2011-02-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy |
A - Award | 7 950 | 7 950 | 62,49 | 496 796 | 496 796 | ||
2011-02-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option, Right to Buy |
A - Award | 1 600 | 1 600 | 62,49 | 99 984 | 99 984 | ||
2011-02-02 |
|
4/A | SIAL |
SIGMA ALDRICH CORP
Common Stock, Right to Buy |
A - Award | 600 | 3 540 | 20,41 | 48,61 | 29 166 | 172 079 | |
2011-02-02 |
|
4/A | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy |
A - Award | 5 674 | 5 674 | 48,61 | 275 813 | 275 813 | ||
2011-02-02 |
|
4/A | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option, $1 Par Value |
A - Award | 2 826 | 2 826 | 48,61 | 137 372 | 137 372 | ||
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option Right To Buy |
M - Exercise | −1 400 | 2 000 | −41,18 | ||||
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right To Buy |
M - Exercise | −4 100 | 0 | −100,00 | ||||
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −200 | 4 140 | −4,61 | 62,71 | −12 542 | 259 619 | |
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −100 | 4 340 | −2,25 | 62,70 | −6 270 | 272 130 | |
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −1 100 | 4 440 | −19,86 | 62,70 | −68 971 | 278 392 | |
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −932 | 5 540 | −14,40 | 62,70 | −58 436 | 347 358 | |
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −328 | 6 472 | −4,82 | 69,69 | −22 858 | 451 034 | |
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −328 | 6 800 | −4,60 | 62,68 | −20 559 | 426 224 | |
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −2 512 | 7 128 | −26,06 | 62,70 | −157 502 | 446 926 | |
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 1 400 | 9 640 | 16,99 | 28,66 | 40 124 | 276 282 | |
2010-11-01 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 4 100 | 8 240 | 99,03 | 28,66 | 117 506 | 236 158 | |
2010-02-18 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock, $1 Par Value |
A - Award | 600 | 4 140 | 16,95 | 48,61 | 29 166 | 201 245 | |
2010-02-18 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy |
A - Award | 5 674 | 5 674 | 48,61 | 275 813 | 275 813 | ||
2010-02-18 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option, Right to Buy |
A - Award | 2 826 | 2 826 | 48,61 | 137 372 | 137 372 | ||
2010-02-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right To Buy |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2010-02-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −5 000 | 2 940 | −62,97 | 48,50 | −242 500 | 142 590 | |
2010-02-16 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 5 000 | 7 940 | 170,07 | 25,86 | 129 300 | 205 328 | |
2009-09-04 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option Right To Buy |
M - Exercise | −5 000 | 5 000 | −50,00 | ||||
2009-09-04 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −100 | 2 940 | −3,29 | 49,85 | −4 985 | 146 568 | |
2009-09-04 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −100 | 3 040 | −3,18 | 49,85 | −4 985 | 151 552 | |
2009-09-04 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −200 | 3 140 | −5,99 | 49,85 | −9 970 | 156 532 | |
2009-09-04 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −1 400 | 3 340 | −29,54 | 49,85 | −69 790 | 166 499 | |
2009-09-04 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
S - Sale | −3 200 | 4 740 | −40,30 | 49,84 | −159 494 | 236 251 | |
2009-09-04 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock |
M - Exercise | 5 000 | 7 940 | 170,07 | 25,86 | 129 300 | 205 328 | |
2009-02-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Common Stock $1 Par Value |
A - Award | 540 | 2 940 | 22,50 | 37,56 | 20 282 | 110 426 | |
2009-02-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
ISO Stock Option |
A - Award | 1 732 | 1 732 | 37,56 | 65 054 | 65 054 | ||
2009-02-19 |
|
4 | SIAL |
SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy |
A - Award | 3 268 | 3 268 | 37,56 | 122 746 | 122 746 | ||
2006-05-03 |
|
4 | SIAL |
SIGMA ALDRICH CORP
Stock Option, Right To Buy |
A - Award | 3 750 | 3 750 | 68,06 | 255 225 | 255 225 |